Remdesivir GS-5734 CAS 1809249-37-3 COVID-19 API Ogo dị elu
Onye nrụpụta Azụmahịa Remdesivir na ihe ndị metụtara ya nwere ogo dị elu
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy) (phenoxy) phosphoryl) -L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosfinyl] -L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S) -2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Metabolite Remdesivir (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Aha Chemical | Remdesivir |
Ụdị okwu | GS-5734;2-ethylbutyl ((S)-((2R,3S,4R,5R) -5- (4-aminopyrrolo [2,1-f][1,2,4]triazin-7-yl) -5-cyano -3,4-dihydroxytetrahydrofuran-2-yl) methoxy) (phenoxy) phosphoryl - L-alaninate. |
Nọmba CAS | 1809249-37-3 |
Nọmba CAT | RF-API96 |
Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
Usoro ihe omimi | C27H35N6O8P |
Ibu molekụla | 602.58 |
Njupụta | 1.47±0.1 g/cm3 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ụtụ siri ike na-acha ọcha ruo na-acha ọcha |
njirimara A | IR: Ụdị nnabata infrared nke ngwaahịa kwesịrị ịdị na nke ihe ntụnyere aka |
njirimara B | Oge njide HPLC yiri ihe ntụaka |
Ntụgharị akọwapụtara | -19.0° ~ -22.0° |
Solubility | Solunle na methanol, Na-agbaze obere na Ethanol, Soluble obere na Acetonitrile, Na-adịghị Azịza nke ọma na Mmiri |
Ihe ndị emetụtara | |
Ọdịghị ọcha nke Onye ọ bụla | ≤0.10% |
Mgbakọta adịghị ọcha | ≤1.0% |
RD-3.1 | ≤0.10% |
RD-C | ≤0.10% |
RD-D | ≤0.10% |
RD-E | ≤0.10% |
RP-Isomer | ≤0.10% |
Nitrophenol | ≤0.10% |
Ihe mgbaze fọdụrụnụ | |
Methanol dichloride | ≤6000ppm |
Acetone | ≤5000ppm |
Isopropyl mmanya | ≤5000ppm |
Acetonitrile | ≤410ppm |
Dichloromethane | ≤600ppm |
Methyl tert Butyl Ether | ≤5000ppm |
Ethyl acetate | ≤5000ppm |
Tetrahydrofuran | ≤720ppm |
n-Heptane | ≤5000ppm |
Nyocha | 98.0% ~ 102.0% (gbakọọ na nke a mịrị amị) |
Ngụkọta ọnụ ọgụgụ ikuku | |
Aerobic nje bacteria | ≤100cfu/g |
Yist na ebu | ≤10cfu/g |
E. Igwe mmiri | Ihe ọjọọ |
Endotoxin nke nje bacteria | ≤1.0EU |
Ọla dị arọ | ≤20ppm |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | API, COVID-19 |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
Remdesivir (CAS 1809249-37-3), nke a na-ere n'okpuru akara aha Veklury, bụ ọgwụ mgbochi dị iche iche nke ụlọ ọrụ biopharmaceutical Gilead Sciences mepụtara.A na-enye ya site na injections n'ime vein.N'oge ọrịa COVID-19, akwadoro ma ọ bụ nye ikike remdesivir maka iji ihe mberede gwọọ COVID-19 n'ihe dị ka mba 50.Ntuziaka emelitere sitere na Healthtù Ahụ Ike wa na Nọvemba 2020 gụnyere ntụnye ọnọdụ megide iji Remdesivir maka ọgwụgwọ COVID-19.Emebere Remdesivir ka ọ gwọọ ịba ọcha n'anya C, ma emesịa nyocha ya maka ọrịa nje Ebola na nje Marburg tupu a mụọ ya dị ka ọgwụgwọ ọrịa na-efe efe maka COVID-19.Mmetụta kachasị emetụta ndị ọrụ afọ ofufo ahụike bụ mmụba ọbara nke enzymes imeju (ihe ịrịba ama nke nsogbu imeju).Mmetụta kachasị emetụta ndị nwere COVID-19 bụ ọgbụgbọ.Mmetụta nwere ike ịgụnye mbufụt imeju na mmeghachi omume metụtara infusion na ọgbụgbọ, ọbara mgbali elu, na ọsụsọ.Remdesivir bụ prodrug nke ezubere inye ohere nnyefe intracellular nke GS-441524 monophosphate na biotransformation na-esote n'ime GS-441524 triphosphate, ihe mgbochi analog nke ribonucleotide nke viral RNA polymerase.